Invention Grant
- Patent Title: Ganaxolone for use in treatment of status epilepticus
-
Application No.: US17186569Application Date: 2021-02-26
-
Publication No.: US11110100B2Publication Date: 2021-09-07
- Inventor: David Czekai , Maciej Gasior , Lorianne Masuoka , Julia Tsai , Joseph Hulihan , Alex Aimetti
- Applicant: Marinus Pharmaceuticals, Inc.
- Applicant Address: US PA Radnor
- Assignee: Marinus Pharmaceuticals, Inc.
- Current Assignee: Marinus Pharmaceuticals, Inc.
- Current Assignee Address: US PA Radnor
- Agency: Hogan Lovells US LLP
- Main IPC: A61K31/573
- IPC: A61K31/573 ; A61P25/08 ; A61K9/00
Abstract:
This invention relates to methods for treating status epilepticus by administering to the subject in need thereof an intravenous bolus of ganaxolone and a continuous intravenous infusion of a neurosteroid. The method provides SE suppression and continued suppression of SE.
Public/Granted literature
- US20210186987A1 GANAXOLONE FOR USE IN TREATMENT OF STATUS EPILEPTICUS Public/Granted day:2021-06-24
Information query
